The relationship between secondary hyperparathyroidism and thyroid cancer in end stage renal disease: A population based cohort study

European Journal of Internal Medicine

Volumn 25, Issue 3, 2014, Pages 276-280

  Lin, Shih Yi ^a,b   Lin, Wei Ming ^c,d   Lin, Cheng Li ^b,e   Yang, Tse Yen ^b   Sung, Fung Chang ^b,e   Wang, Yuan Hung ^f,g   Kao, Chia Hung ^b,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

End stage renal disease; Hyperparathyroidism; Thyroid cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; POPULATION RESEARCH; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; TAIWAN; THYROID CANCER; YOUNG ADULT; CHRONIC KIDNEY FAILURE; COMPLICATION; RISK ASSESSMENT; THYROID NEOPLASMS;

AGED; COHORT STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TAIWAN; THYROID NEOPLASMS;

EID: 84896397090     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.01.001     Document Type: Article

References (26)

1. S. Kato, M. Chmielewski, H. Honda, R Pecoits-Filho, S Matsuo, and Y Yuzawa et al. Aspects of immune dysfunction in end-stage renal disease Clin J Am Soc Nephrol 3 2008 1526 1533
2. M.G. Betjes Immune cell dysfunction and inflammation in end-stage renal disease Nat Rev Nephrol 9 2013 255 265
3. P. Maisonneuve, L. Agodoa, R. Gellert, JH Stewart, G Buccianti, and AB Lowenfels et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Lancet 354 1999 93 99
4. H.F. Lin, Y.H. Li, C.H. Wang, CL Chou, DJ Kuo, and TC Fang et al. Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan Nephrol Dial Transplant 27 2012 1585 1590
5. J.A. Liang, L.M. Sun, and J.J. Yeh et al. The association between malignancy and end-stage renal disease in Taiwan Jpn J Clin Oncol 41 2011 752 757
6. C.J. Chung, C.Y. Huang, H.B. Tsai, CH Muo, MC Chung, and CH Chang et al. Sex differences in the development of malignancies among end-stage renal disease patients: a nationwide population-based follow-up study in Taiwan PLoS One 7 2012 e44675
7. M.M. Salem Hyperparathyroidism in the hemodialysis population: a survey of 612 patients Am J Kidney Dis 29 1997 862 865
8. Y. Nishizawa, T. Shoji, T. Kawagishi, and H. Morii Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation Kidney Int Suppl 62 1997 S90 S92
9. R.N. Moorthi, and S.M. Moe CKD-mineral and bone disorder: core curriculum 2011 Am J Kidney Dis 58 2011 1022 1036
10. S.M. Sprague, and S.M. Moe The case for routine parathyroid hormone monitoring Clin J Am Soc Nephrol 8 2013 313 318
11. C. Yasunaga, M. Nakamoto, K. Matsuo, G. Nishihara, T. Yoshida, and T. Goya Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism Am J Surg 178 1999 332 336
12. A.L. Pickard, G. Gridley, L. Mellemkjæ, C Johansen, A Kofoed-Enevoldsen, and KP Cantor et al. Hyperparathyroidism and subsequent cancer risk in Denmark Cancer 95 2002 1611 1617
13. K.B. Michels, F. Xue, L. Brandt, and A. Ekbom Hyperparathyroidism and subsequent incidence of breast cancer Int J Cancer 110 2004 449 451
14. I.-L. Nilsson, J. Zedenius, L. Yin, and A. Ekbom The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy Endocr Relat Cancer 14 2007 135 140
15. C.L. Cheng, Y.H. Kao, S.J. Lin, C.H. Lee, and M.L. Lai Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan Pharmacoepidemiol Drug Saf 20 2011 236 242
16. J.H. Kang, Y.H. Chen, and H.C. Lin Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study Ann Rheum Dis 69 2010 1165 1168
17. I.J. Fedorak, G. Salti, N. Fulton, C. Schark, F.H. Straus II, and E.L. Kaplan Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: a continuing dilemma Am Surg 60 1994 427 431
18. S.D. Wilson, K.M. Doffek, T.S. Wang, E.A. Krzywda, D.B. Evans, and T.W. Yen Primary hyperparathyroidism with a history of head and neck irradiation: the consequences of associated thyroid tumors Surgery 150 2011 869 877
19. M.Q. Almeida, and C.A. Stratakis Solid tumors associated with multiple endocrine neoplasias Cancer Genet Cytogenet 203 2010 30 36
20. A.S. Geara, M.R. Castellanos, C. Bassil, G Schuller-Levis, E Park, and M Smith et al. Effects of parathyroid hormone on immune function Clin Dev Immunol 41865 2010 1 10
21. C. Tzanno-Martins, E. Futata, V. Jorgetti, and A.J. Duarte Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared? Clin Nephrol 54 2005 22 29
22. C. Marcocci, and F. Cetani Primary hyperparathyroidism N Engl J Med 365 2011 2389 2397
23. H.C. Lin, C.L. Chen, H.S. Lin, KJ Chou, HC Fang, and SI Liu et al. Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism Clin Endocrinol (Oxf) 2013 19 [Epub ahead]
24. M. Fukagawa, H. Komaba, and T. Kakuta Hyperparathyroidism in chronic kidney disease patients: an update on current pharmacotherapy Expert Opin Pharmacother 14 2013 863 871
25. D. Gracie, and S.S. Hussain Use of minimally invasive parathyroidectomy techniques in sporadic primary hyperparathyroidism: systematic review J Laryngol Otol 126 2012 221 227
26. C.A. Arciero, Z.S. Shiue, J.D. Gates, GE Peoples, AP Dackiw, and RP Tufano et al. Preoperative thyroid ultrasound is indicated in patients undergoing parathyroidectomy for primary hyperparathyroidism J Cancer 3 2012 1 6